THE ADDED VALUE OF DIFFUSION-WEIGHTED IMAGING AND DYNAMIC CONTRAST-ENHANCED SEQUENCES IN THE DIAGNOSIS OF LOCALIZED RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FORECAST TRIAL